Grow your business safely with EUROFINS NEW PHARMA 2019
All the information you need about EUROFINS NEW PHARMA 2019 to develop and secure your business in France
E
HOME >
CORPORATES
>
EUROFINS NEW PHARMA 2019 >
BALANCE SHEET (
2021-06-29)
THE LIST OF BALANCE SHEET : EUROFINS NEW PHARMA 2019
| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-06-28 | Public | 2021-12-31 | Complete |
| 2021-06-29 | Public | 2020-12-31 | Complete |
| 2020-07-01 | Public | 2019-12-31 | Complete |
| 2019-05-16 | Public | 2018-12-31 | Complete |
| Name | Eurofins Clinical Trial Supplies France |
| Siren | 844974121 |
| Closing | 2020-12-31 |
| Registry code | 4401 |
| Registration number | 13202 |
| Management number | 2018B03615 |
| Activity code | 7120B |
| Closing date n-1 | 2019-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2021-06-29 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 44300 NANTES |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BZ Other receivables | 2 374.00 | 2 374.00 | 2 374.00 | |
CF Cash and cash equivalents | 2 918.00 | 2 918.00 | 2 918.00 | |
CJ TOTAL (II) | 5 292.00 | 5 292.00 | 5 292.00 | |
CO Grand total (0 to V) | 5 292.00 | 5 292.00 | 5 292.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 15 551.00 | 15 000.00 | 15 551.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | -12 370.00 | -10 449.00 | -12 370.00 | |
DL TOTAL (I) | 3 181.00 | 4 551.00 | 3 181.00 | |
DX Trade payables and related accounts | 2 111.00 | 9 158.00 | 2 111.00 | |
DY Tax and social security liabilities | 132.00 | |||
EC TOTAL (IV) | 2 111.00 | 9 290.00 | 2 111.00 | |
EE Grand total (I to V) | 5 292.00 | 13 841.00 | 5 292.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 12 370.00 | |||
FZ Social Security Contributions | 6.00 | |||
GF Total Operating Expenses (II) | 12 370.00 | |||
GG - OPERATING RESULT (I - II) | -12 370.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -12 370.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 12 370.00 | 10 449.00 | 12 370.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | -12 370.00 | -10 449.00 | -12 370.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 2 111.00 | 2 111.00 | 2 111.00 | |
VR Miscellaneous debtors (including receivables related to repo transactions) | 2 374.00 | 2 374.00 | 2 374.00 | |
VT TOTAL – STATEMENT OF RECEIVABLES | 2 374.00 | 2 374.00 | 2 374.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 2 111.00 | 2 111.00 | 2 111.00 | |
all companies in France
Complete and comprehensive database.
